Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Gene Therapy Market From 2025 to 2029?

There has been a significant expansion in the gene therapy market over the recent years. The market, which stood at $12.52 billion in 2024, will escalate to $16.36 billion by 2025, marking a compound annual growth rate (CAGR) of 30.7%. The remarkable growth during the historical period can be attributed to factors such as increasing pharmaceutical R&D spendings, a surge in public-private collaborations, government funding and a rise in instances of spinal muscular atrophy.

In the coming years, the gene therapy market is predicted to experience significant expansion. It is projected to reach a value of “$31.48 billion in 2029, growing at a compound annual growth rate (CAGR) of 17.8%.” Factors influencing this trend include escalating cancer incidences, an expanding elderly population, increase in pharmaceutical research and development expenditure, and a heightened focus on gene therapy. Major forthcoming trends include procuring necessary regulatory approvals to improve business operations, strategic collaborations and partnerships to bolster commercial activities, strategic acquisitions to broaden operational capabilities, and business expansion for enhancing operational proficiency.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What Elements Are Contributing To Growth In The Gene Therapy Market?

There has been a substantial uptick in cases of cancer and other such critical diseases, necessitating the need for potent treatment methods and fuels the growth of the gene therapy market. The global escalation in cancer incidence is projected to influence gene therapy market expansion in the upcoming period. For example, the American Cancer Society provided data in January 2022, suggesting that there will probably be 1.9 million new cancer diagnoses and an estimated 609,360 cancer-related fatalities in the US, which is approximately 1,670 deaths on daily basis. The four cancers that are most commonly diagnosed worldwide – lung, prostate, bowel, and female breast cancer, make up for about 43 percent of all newly diagnosed cancer cases worldwide. Thus, the global surge in cancer occurrence is expected to stimulate demand in the gene therapy market in the near future. Gene therapy, which involves the introduction of new genes into cancerous cells or nearby tissue to provoke cell death or reduce cancer growth, is a highly effective treatment in oncology.

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Which Emerging Trends And Strategic Shifts Are Shaping The Gene Therapy Market?

The gene therapy market is increasingly integrating artificial intelligence (AI) and machine learning into its operations. AI imitates human cognitive abilities within computers, while machine learning is a subset of this field. These technologies aid organizations in the gene therapy sector in conducting comprehensive data analysis, drawing connections between tumor and immune cell interactions, and providing more precise assessments of tissue samples that are usually contested among various analysts. For instance, Form Bio, an American software firm specializing in life-sciences, released FORMsightAI in May 2023. This new AI-driven solution predicts and optimizes the production results of cell and gene therapy constructs. FORMsightAI is a comprehensive solution that blends advanced, flexible AI models with Form Bio’s foundational platform and the expertise of a talented team of computational life scientists with experience in biology, bioinformatics, and data science. It tackles prevalent problems encountered by cell and gene therapy developers regarding construct truncations and manufacturing contaminate, which are significant contributors to low production yields, increased market entry timelines, and therapeutic safety issues.

Who Are The Key Contributors To Growth In The Gene Therapy Market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Is Projected To Lead The Gene Therapy Market By 2025?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model